Walking Program in Fatty Liver Children With Phenylketonuria
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9-12
SponsorCairo University
About this trial
phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many metabolic complication including non-alcoholic fatty liver
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
PKU children
obese children
fatty liver children (non-alcoholic fatty liver)
Disqualifiers
cardiac children
diabetic children
neurogenic disorders
respiratory and renal problems
Trial design
Design model
Parallel
Treatments tested in this trial
walking free online supervised program
Behavioralthis Group I will include PKU children sufferers (n=20) with non-alcoholic fatty liver that will perform walking program (online supervised free walking that will be applied daily for eight weeks)
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: group IExperimental treatment 1 intervention
Group B: Group IINo intervention 0 interventions
Trial outcomes
Primary outcomes
1
alanine transamianse
it is a serum liver enzyme
Time frame
it will be assessed after eight weeksSecondary outcomes
1
aspartate tranaminase
it is a serum liver enzyme
Time frame
it will be assessed after eight weeks2
Gamma-glutamyl Transferase
it is a serum liver enzyme
Time frame
it will be assessed after eight weeks3
alkaline phosphatase
it is a serum liver enzyme
Time frame
it will be assessed after eight weeks4
triglycerides
it will be measured in the serum
Time frame
it will be assessed after eight weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov